Article

Pharmaceutical Executive

Santhera Selects Veeva Systems for Product Launch

Santhera Pharmaceuticals, rare disease pharmaceutical company, has selected Veeva CRM and Veeva OpenData as a commercial software and data platform for its first product launch. The platform will be used to help Santhera establish a consistent, global approach to commercialization as it offers up-to-date customer reference data for field teams to enable faster, tailored interactions with HCPs.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Gen Li
Ted Sweetser
Ted Sweetser
Ted Sweetser
Related Content
Sujay Jadhav
August 6th 2025

Fail Fast, Save Smart: A Silicon Valley Approach to Drug Development Could Cut Costs and Improve Access

Sujay Jadhav
By using real-world data (RWD) and the insights derived from it, real-world evidence (RWE) earlier in research and development, drugmakers can make more informed decisions and reduce the financial risks that drive up drug prices.
Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
August 6th 2025

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.
Credit: Shuo | stock.adobe.com
August 6th 2025

Six Essential Priorities for Life Sciences Chief Information Officers

Alister Campbell
Organizations commonly navigate outdated systems that make collaboration harder and breakthroughs slower, causing delays, missed insights, and costly rework.
Gaugarin Oliver
August 6th 2025

Navigating Uncertainty with AI: Building Trust in the Way Forward

Gaugarin Oliver
Despite surging GenAI adoption in pharma and the FDA’s recent embrace of the technology, a trust gap remains with GenAI implementations. The story describes four essentials that improve trust in GenAI so that pharma and biotech teams can better navigate the present time of uncertainty.
Zifo Survey Shows Biopharma Racing Toward AI Despite Data Management Challenges
August 6th 2025

Zifo Survey Shows Biopharma Racing Toward AI Despite Data Management Challenges

Don Tracy, Associate Editor
A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but highlights gaps in data integration, standardization, and infrastructure that threaten to stall progress.
Stock.adobe.com
August 6th 2025

Can AI Accelerate Clinical Review at FDA?

PharmExec Staff
With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug review and speed up approval is not here yet.